Literature DB >> 28087669

The Role of the p38-MNK-eIF4E Signaling Axis in TNF Production Downstream of the NOD1 Receptor.

Mikhail V Pashenkov1, Lyudmila S Balyasova2, Yulia A Dagil2, Boris V Pinegin2.   

Abstract

Activation of nucleotide-binding oligomerization domain (NOD) 1 and NOD2 by muropeptides triggers a complex transcriptional program in innate immune cells. However, little is known about posttranscriptional regulation of NOD1- and NOD2-dependent responses. When stimulated with a prototypic NOD1 agonist, N-acetylglucosaminyl-N-acetylmuramyl-l-alanyl-d-isoglutamyl-meso-diaminopimelic acid (GM-triDAP), human monocyte-derived macrophages (MDM) produced an order of magnitude more TNF, IL-6, and pro-IL-1β than did monocyte-derived dendritic cells (MDDC), despite similar NOD1 expression, similar cytokine mRNA kinetics, and comparable responses to LPS. TNF production by GM-triDAP-activated MDM was independent of autocrine IL-1. However, GM-triDAP-activated MDM translated TNF mRNA more efficiently than did MDDC. As an underlying mechanism, NOD1 triggering in MDM caused a more potent and long-lasting activation of the signaling axis involving p38 MAPK, MAPK-interacting kinase (MNK), and eukaryotic translation initiation factor 4E, which is a critical regulator of translation. Furthermore, MNK controlled TNF mRNA abundance in MDDC and MDM upon NOD1 triggering. NOD1-dependent responses were more sensitive to MNK inhibition than were TLR4-dependent responses. These results demonstrate the importance of the p38-MNK-eukaryotic translation initiation factor 4E axis in TNF production downstream of NOD1.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28087669     DOI: 10.4049/jimmunol.1600467

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Glycolytic reprogramming of macrophages activated by NOD1 and TLR4 agonists: No association with proinflammatory cytokine production in normoxia.

Authors:  Nina E Murugina; Anna S Budikhina; Yulia A Dagil; Polina V Maximchik; Lyudmila S Balyasova; Vladimir V Murugin; Mikhail V Melnikov; Viktoriya S Sharova; Anna M Nikolaeva; Georgy Z Chkadua; Boris V Pinegin; Mikhail V Pashenkov
Journal:  J Biol Chem       Date:  2020-01-31       Impact factor: 5.157

2.  TNF Production in Activated RBL-2H3 Cells Requires Munc13-4.

Authors:  Tolulope E Ayo; Pratikshya Adhikari; Shuzo Sugita; Hao Xu
Journal:  Inflammation       Date:  2020-04       Impact factor: 4.092

3.  eIF4E phosphorylation regulates ongoing pain, independently of inflammation, and hyperalgesic priming in the mouse CFA model.

Authors:  Jamie K Moy; Jasper L Kuhn; Thomas A Szabo-Pardi; Grishma Pradhan; Theodore J Price
Journal:  Neurobiol Pain       Date:  2018-03-15

4.  Glutamate alleviates intestinal injury, maintains mTOR and suppresses TLR4 and NOD signaling pathways in weanling pigs challenged with lipopolysaccharide.

Authors:  Qin Qin; Xiao Xu; Xiuying Wang; Huanting Wu; Huiling Zhu; Yongqing Hou; Bing Dai; Xiuting Liu; Yulan Liu
Journal:  Sci Rep       Date:  2018-10-11       Impact factor: 4.379

Review 5.  Innate immunity in allergy.

Authors:  Kazuhiko Maeda; Matias J Caldez; Shizuo Akira
Journal:  Allergy       Date:  2019-04-14       Impact factor: 13.146

Review 6.  Deeping in the Role of the MAP-Kinases Interacting Kinases (MNKs) in Cancer.

Authors:  Celia Pinto-Díez; Raquel Ferreras-Martín; Rebeca Carrión-Marchante; Víctor M González; María Elena Martín
Journal:  Int J Mol Sci       Date:  2020-04-23       Impact factor: 5.923

7.  Neuroimmune Consequences of eIF4E Phosphorylation on Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Nilesh M Agalave; Prapti H Mody; Thomas A Szabo-Pardi; Han S Jeong; Michael D Burton
Journal:  Front Immunol       Date:  2021-04-12       Impact factor: 7.561

Review 8.  Regulation of Immune Homeostasis via Muramyl Peptides-Low Molecular Weight Bioregulators of Bacterial Origin.

Authors:  Svetlana V Guryanova
Journal:  Microorganisms       Date:  2022-07-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.